CN1206351C - 一种溶菌酶蛋白生产工艺及其应用 - Google Patents
一种溶菌酶蛋白生产工艺及其应用 Download PDFInfo
- Publication number
- CN1206351C CN1206351C CN 01132373 CN01132373A CN1206351C CN 1206351 C CN1206351 C CN 1206351C CN 01132373 CN01132373 CN 01132373 CN 01132373 A CN01132373 A CN 01132373A CN 1206351 C CN1206351 C CN 1206351C
- Authority
- CN
- China
- Prior art keywords
- protein
- present
- lysozyme
- cell
- sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000000034 method Methods 0.000 title claims abstract description 34
- 108010014251 Muramidase Proteins 0.000 title abstract description 15
- 102000016943 Muramidase Human genes 0.000 title abstract description 15
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 title abstract description 15
- 230000008569 process Effects 0.000 title description 8
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 46
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 37
- 101001018100 Homo sapiens Lysozyme C Proteins 0.000 claims abstract description 24
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 45
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 42
- 229920001184 polypeptide Polymers 0.000 claims description 39
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 39
- 210000004027 cell Anatomy 0.000 claims description 31
- 239000002773 nucleotide Substances 0.000 claims description 31
- 125000003729 nucleotide group Chemical group 0.000 claims description 31
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 15
- 239000013604 expression vector Substances 0.000 claims description 5
- 230000008859 change Effects 0.000 claims description 4
- 210000003527 eukaryotic cell Anatomy 0.000 claims description 3
- 239000008176 lyophilized powder Substances 0.000 claims description 3
- 238000005516 engineering process Methods 0.000 abstract description 14
- 229960000274 lysozyme Drugs 0.000 abstract description 11
- 235000010335 lysozyme Nutrition 0.000 abstract description 11
- 239000004325 lysozyme Substances 0.000 abstract description 11
- 238000004519 manufacturing process Methods 0.000 abstract description 10
- 238000000746 purification Methods 0.000 abstract description 10
- 230000000694 effects Effects 0.000 abstract description 9
- 238000000926 separation method Methods 0.000 abstract description 9
- 241001465754 Metazoa Species 0.000 abstract description 7
- 230000008901 benefit Effects 0.000 abstract description 2
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 238000009776 industrial production Methods 0.000 abstract 1
- 235000018102 proteins Nutrition 0.000 description 29
- 150000001413 amino acids Chemical class 0.000 description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 20
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 18
- 108010064696 N,O-diacetylmuramidase Proteins 0.000 description 18
- 235000001014 amino acid Nutrition 0.000 description 18
- 239000007788 liquid Substances 0.000 description 17
- 239000000047 product Substances 0.000 description 17
- 238000000855 fermentation Methods 0.000 description 15
- 230000004151 fermentation Effects 0.000 description 15
- 239000013612 plasmid Substances 0.000 description 15
- 239000012634 fragment Substances 0.000 description 13
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 11
- 239000001301 oxygen Substances 0.000 description 11
- 229910052760 oxygen Inorganic materials 0.000 description 11
- 239000000523 sample Substances 0.000 description 11
- 239000000243 solution Substances 0.000 description 10
- 235000011187 glycerol Nutrition 0.000 description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 8
- 238000011081 inoculation Methods 0.000 description 8
- 239000006228 supernatant Substances 0.000 description 8
- 241000894006 Bacteria Species 0.000 description 7
- 102000004190 Enzymes Human genes 0.000 description 7
- 108090000790 Enzymes Proteins 0.000 description 7
- 239000008367 deionised water Substances 0.000 description 7
- 229910021641 deionized water Inorganic materials 0.000 description 7
- 229940088598 enzyme Drugs 0.000 description 7
- 230000001954 sterilising effect Effects 0.000 description 7
- 239000003795 chemical substances by application Substances 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 229940041514 candida albicans extract Drugs 0.000 description 5
- 238000005374 membrane filtration Methods 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- 108091008146 restriction endonucleases Proteins 0.000 description 5
- 238000004659 sterilization and disinfection Methods 0.000 description 5
- 239000012138 yeast extract Substances 0.000 description 5
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- 239000001888 Peptone Substances 0.000 description 4
- 108010080698 Peptones Proteins 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 4
- 230000001580 bacterial effect Effects 0.000 description 4
- 239000000872 buffer Substances 0.000 description 4
- 238000005520 cutting process Methods 0.000 description 4
- 108020004707 nucleic acids Proteins 0.000 description 4
- 102000039446 nucleic acids Human genes 0.000 description 4
- 150000007523 nucleic acids Chemical class 0.000 description 4
- 235000019319 peptone Nutrition 0.000 description 4
- 238000001556 precipitation Methods 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- 238000012546 transfer Methods 0.000 description 4
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 3
- 108020004705 Codon Proteins 0.000 description 3
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 241000238631 Hexapoda Species 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 241000276498 Pollachius virens Species 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- GZCGUPFRVQAUEE-SLPGGIOYSA-N aldehydo-D-glucose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O GZCGUPFRVQAUEE-SLPGGIOYSA-N 0.000 description 3
- 125000000539 amino acid group Chemical group 0.000 description 3
- 238000000502 dialysis Methods 0.000 description 3
- 238000001962 electrophoresis Methods 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 238000004108 freeze drying Methods 0.000 description 3
- 230000013595 glycosylation Effects 0.000 description 3
- 238000006206 glycosylation reaction Methods 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- 230000003053 immunization Effects 0.000 description 3
- 238000002649 immunization Methods 0.000 description 3
- 230000000968 intestinal effect Effects 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 238000010926 purge Methods 0.000 description 3
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 3
- 239000000600 sorbitol Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 230000014616 translation Effects 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- NOIIUHRQUVNIDD-UHFFFAOYSA-N 3-[[oxo(pyridin-4-yl)methyl]hydrazo]-N-(phenylmethyl)propanamide Chemical compound C=1C=CC=CC=1CNC(=O)CCNNC(=O)C1=CC=NC=C1 NOIIUHRQUVNIDD-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241000194107 Bacillus megaterium Species 0.000 description 2
- 241001478240 Coccus Species 0.000 description 2
- 241000186031 Corynebacteriaceae Species 0.000 description 2
- 241000598860 Garcinia hanburyi Species 0.000 description 2
- 229920002683 Glycosaminoglycan Polymers 0.000 description 2
- 241000186660 Lactobacillus Species 0.000 description 2
- 241000192041 Micrococcus Species 0.000 description 2
- 241000191938 Micrococcus luteus Species 0.000 description 2
- 208000022873 Ocular disease Diseases 0.000 description 2
- 238000012408 PCR amplification Methods 0.000 description 2
- 241000192023 Sarcina Species 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 241000191940 Staphylococcus Species 0.000 description 2
- 229930003756 Vitamin B7 Natural products 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 150000001447 alkali salts Chemical class 0.000 description 2
- 230000000845 anti-microbial effect Effects 0.000 description 2
- 230000000692 anti-sense effect Effects 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 230000000890 antigenic effect Effects 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 210000004899 c-terminal region Anatomy 0.000 description 2
- 210000002421 cell wall Anatomy 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 238000005336 cracking Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 239000008121 dextrose Substances 0.000 description 2
- 230000008034 disappearance Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 210000001508 eye Anatomy 0.000 description 2
- 229940117709 gamboge Drugs 0.000 description 2
- 238000009396 hybridization Methods 0.000 description 2
- 210000004408 hybridoma Anatomy 0.000 description 2
- 230000005847 immunogenicity Effects 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- 230000037431 insertion Effects 0.000 description 2
- PHTQWCKDNZKARW-UHFFFAOYSA-N isoamylol Chemical compound CC(C)CCO PHTQWCKDNZKARW-UHFFFAOYSA-N 0.000 description 2
- 229940039696 lactobacillus Drugs 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 230000002934 lysing effect Effects 0.000 description 2
- 230000004481 post-translational protein modification Effects 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 210000001236 prokaryotic cell Anatomy 0.000 description 2
- 238000004062 sedimentation Methods 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 239000011735 vitamin B7 Substances 0.000 description 2
- 235000011912 vitamin B7 Nutrition 0.000 description 2
- 210000005253 yeast cell Anatomy 0.000 description 2
- 208000030507 AIDS Diseases 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 150000008574 D-amino acids Chemical class 0.000 description 1
- 102000012410 DNA Ligases Human genes 0.000 description 1
- 108010061982 DNA Ligases Proteins 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 102000008394 Immunoglobulin Fragments Human genes 0.000 description 1
- 108010021625 Immunoglobulin Fragments Proteins 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241001529936 Murinae Species 0.000 description 1
- BZQFBWGGLXLEPQ-UHFFFAOYSA-N O-phosphoryl-L-serine Natural products OC(=O)C(N)COP(O)(O)=O BZQFBWGGLXLEPQ-UHFFFAOYSA-N 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 101000702488 Rattus norvegicus High affinity cationic amino acid transporter 1 Proteins 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 235000011114 ammonium hydroxide Nutrition 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000001130 anti-lysozyme effect Effects 0.000 description 1
- -1 apery breast Substances 0.000 description 1
- 208000003464 asthenopia Diseases 0.000 description 1
- 238000003287 bathing Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 210000005252 bulbus oculi Anatomy 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000012930 cell culture fluid Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000009514 concussion Effects 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 239000012228 culture supernatant Substances 0.000 description 1
- 238000013016 damping Methods 0.000 description 1
- 230000001877 deodorizing effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 229950006137 dexfosfoserine Drugs 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000019249 food preservative Nutrition 0.000 description 1
- 239000005452 food preservative Substances 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002262 irrigation Effects 0.000 description 1
- 238000003973 irrigation Methods 0.000 description 1
- 210000004962 mammalian cell Anatomy 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 210000001589 microsome Anatomy 0.000 description 1
- 108091005601 modified peptides Proteins 0.000 description 1
- 231100000219 mutagenic Toxicity 0.000 description 1
- 230000003505 mutagenic effect Effects 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- DCWXELXMIBXGTH-QMMMGPOBSA-N phosphonotyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(OP(O)(O)=O)C=C1 DCWXELXMIBXGTH-QMMMGPOBSA-N 0.000 description 1
- 230000026731 phosphorylation Effects 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- BZQFBWGGLXLEPQ-REOHCLBHSA-N phosphoserine Chemical compound OC(=O)[C@@H](N)COP(O)(O)=O BZQFBWGGLXLEPQ-REOHCLBHSA-N 0.000 description 1
- USRGIUJOYOXOQJ-GBXIJSLDSA-N phosphothreonine Chemical compound OP(=O)(O)O[C@H](C)[C@H](N)C(O)=O USRGIUJOYOXOQJ-GBXIJSLDSA-N 0.000 description 1
- 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000004853 protein function Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000002708 random mutagenesis Methods 0.000 description 1
- 238000010188 recombinant method Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 210000000664 rectum Anatomy 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000005185 salting out Methods 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000002741 site-directed mutagenesis Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 229940034610 toothpaste Drugs 0.000 description 1
- 239000000606 toothpaste Substances 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 239000013598 vector Substances 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Landscapes
- Enzymes And Modification Thereof (AREA)
Abstract
Description
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 01132373 CN1206351C (zh) | 2001-11-30 | 2001-11-30 | 一种溶菌酶蛋白生产工艺及其应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 01132373 CN1206351C (zh) | 2001-11-30 | 2001-11-30 | 一种溶菌酶蛋白生产工艺及其应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1366044A CN1366044A (zh) | 2002-08-28 |
CN1206351C true CN1206351C (zh) | 2005-06-15 |
Family
ID=4671401
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 01132373 Expired - Fee Related CN1206351C (zh) | 2001-11-30 | 2001-11-30 | 一种溶菌酶蛋白生产工艺及其应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1206351C (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101698681A (zh) * | 2008-10-10 | 2010-04-28 | 暨南大学 | 一种双靶向作用的嵌合多肽及其应用 |
CN109295088A (zh) * | 2017-07-25 | 2019-02-01 | 上海复华兴生物技术有限公司 | 一种生产具有人溶菌酶蛋白活性多肽的方法及用途 |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102433314A (zh) * | 2012-01-10 | 2012-05-02 | 江苏大学 | 一种重组墨吉明对虾溶菌酶及其制备和应用 |
CN106148303A (zh) * | 2014-11-18 | 2016-11-23 | 复旦大学 | 一种人源溶菌酶蛋白发酵方法 |
CN109295034A (zh) * | 2017-07-25 | 2019-02-01 | 上海复华兴生物技术有限公司 | 一种人源溶菌酶蛋白lyc8及其生产工艺和应用 |
CN107794274A (zh) * | 2017-10-27 | 2018-03-13 | 杭州欧亘生物科技有限公司 | 一种人源溶菌酶蛋白生产工艺 |
CN109810962B (zh) * | 2017-11-22 | 2021-08-10 | 上海复华兴生物技术有限公司 | 一种新的猪源溶菌酶的dna序列及其生产工艺和应用 |
CN108567797A (zh) * | 2018-03-26 | 2018-09-25 | 刘洪武 | 一种蚯蚓洗液 |
-
2001
- 2001-11-30 CN CN 01132373 patent/CN1206351C/zh not_active Expired - Fee Related
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101698681A (zh) * | 2008-10-10 | 2010-04-28 | 暨南大学 | 一种双靶向作用的嵌合多肽及其应用 |
CN101698681B (zh) * | 2008-10-10 | 2014-01-29 | 暨南大学 | 一种双靶向作用的嵌合多肽及其应用 |
CN109295088A (zh) * | 2017-07-25 | 2019-02-01 | 上海复华兴生物技术有限公司 | 一种生产具有人溶菌酶蛋白活性多肽的方法及用途 |
Also Published As
Publication number | Publication date |
---|---|
CN1366044A (zh) | 2002-08-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN109966484B (zh) | 一种免疫增强剂、制备方法、禽流感疫苗和应用 | |
CN112111474B (zh) | 一种酶活性提高的重组溶菌酶lyz-2及其突变体和应用 | |
CN1206351C (zh) | 一种溶菌酶蛋白生产工艺及其应用 | |
CN108066755B (zh) | 一种抗羊包虫病感染的基因工程亚单位疫苗及其制备方法和应用 | |
CN109627316A (zh) | 草鱼IFN-γ2基因及其编码的重组蛋白和应用 | |
CN112851794B (zh) | 一种基于cd271的抗原表位及其应用 | |
CN108531468A (zh) | 编码重组幽门螺杆菌丝氨酸蛋白酶的基因、卵黄抗体与应用 | |
CN1865286A (zh) | 双功能表皮生长因子及其制备方法和用途 | |
CN110295134A (zh) | 一种表面展示C型产气荚膜梭菌α、β毒素蛋白重组植物乳杆菌的构建及其应用 | |
CN111454336B (zh) | 一种改造的鸭圆环病毒Cap蛋白及其制备方法和应用 | |
CN101280015B (zh) | 可溶性人源含硒单链抗体酶的制备方法 | |
CN111303276B (zh) | 旋毛虫肠道期半胱氨酸蛋白酶抑制剂的b细胞表位多肽、杂交瘤细胞株、单克隆抗体、应用 | |
CN1803846A (zh) | p53蛋白的表位(SQAMDDLMLS)与丝状噬菌体基因8蛋白的杂合蛋白及其应用 | |
CN1231585C (zh) | 重组鸭白介素2蛋白的制备方法及其用途 | |
CN114736296A (zh) | 成纤维细胞外囊泡制备的药品或化妆品 | |
CN114349856A (zh) | 成纤维细胞外囊泡制备及其在美容和药品中的应用 | |
CN1635119A (zh) | 一种生产老年性痴呆致病物质淀粉样变多肽β(Aβ)的方法及其产物 | |
CN107034198B (zh) | 一种嵌合诺如病毒p颗粒及其制备和应用 | |
CN1847397A (zh) | 抗ehec o157志贺样毒素ⅱa亚单位单克隆抗体5f3轻、重链可变区基因及应用 | |
CN113384691B (zh) | 以沙门氏菌鞭毛蛋白为分子佐剂的猪瘟病毒e2蛋白重组亚单位疫苗及其制备方法 | |
CN113372453B (zh) | 一种融合蛋白及猪流行性腹泻病毒s1蛋白重组亚单位疫苗 | |
CN1232532C (zh) | 成纤维细胞生长因子-2结构类似物,其生产方法及应用 | |
CN112159479B (zh) | 一种鸡毒支原体多抗原表位融合蛋白pMG-mEA及其应用 | |
CN1154655A (zh) | 博代氏杆菌所产皮肤坏死毒素和类毒素的纯化方法 | |
CN105906713B (zh) | 一种猪elf4蛋白卵黄抗体的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: SHANGHAI FUDAN CAREER MANAGEMENT CO., LTD. Free format text: FORMER OWNER: FUDAN UNIVERSITY Effective date: 20081107 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20081107 Address after: Room 1, building 335, No. 8003, National Road, Shanghai, Yangpu District Patentee after: Shanghai Fudan Venture Management Co., Ltd. Address before: No. 220, Handan Road, Shanghai, Yangpu District Patentee before: Fudan University |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20150928 Address after: 201409 Shanghai City, Mao Fengxian District Road No. 659 building 509 room branch Patentee after: Shanghai Huaxing biotech Co., Ltd. Address before: 200433, room 1, building 335, No. 8003, National Road, Shanghai, Yangpu District Patentee before: Shanghai Fudan Venture Management Co., Ltd. |
|
DD01 | Delivery of document by public notice |
Addressee: Shanghai Huaxing biotech Co., Ltd. Document name: Notification of Termination of Patent Right |
|
DD01 | Delivery of document by public notice | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20050615 Termination date: 20181130 |
|
CF01 | Termination of patent right due to non-payment of annual fee |